01 1Cdymax
01 1SUNITINIB MALATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-02-23
Pay. Date : 2021-10-29
DMF Number : 36392
Submission : 2021-10-12
Status : Active
Type : II
20
Cdymax (india) Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SUNITINIB MALATE, with a corresponding US DMF Number 36392.
Remarkably, this DMF maintains an Active status since its submission on October 12, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 23, 2022, and payment made on October 29, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
